Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results

Intellia Therapeutics (NTLA) Misses Q4 EPS by 9c, Revenues Miss

February 25, 2021 7:39 AM EST

Intellia Therapeutics (NASDAQ: NTLA) reported Q4 EPS of ($0.69), $0.09 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $14.09 million.

Intellias achievements in 2020 reflect important progress on both our full-spectrum strategy and our mission to deliver... More